Skip to content

Medical-device intelligence

LAO: Enzyme Immunoassay, Methotrexate

FDA product code LAO: Enzyme Immunoassay, Methotrexate. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LAO
FDA device name
Enzyme Immunoassay, Methotrexate
Device class
U
Regulation number
Not provided
Medical specialty
Unknown
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore unknown records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

10 clearance records and 2 recall records in the covered releases, across 8 source company names and 1 product codes. Dated history runs from Oct 10, 1978 to Feb 20, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LAO · Enzyme Immunoassay, Methotrexate102

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

12 matching records
Device / recordCompany in FDA recordSourceSource date
ONLINE TDM MethotrexateK233454 · LAORoche Diagnostics Operations510(k)Feb 20, 2024FDA decision date
ARK Methotrexate II AssayK232017 · LAOArk Diagnostics, Inc.510(k)Dec 20, 2023FDA decision date
ARK Methotrexate AssayK163359 · LAOArk Diagnostics, Inc.510(k)Aug 18, 2017FDA decision date
Syva Emit Methotrexate Assay, is a homogeneous enzyme immunoassay intended for use in the quantitative analysis of methotrexate in human serum or…Z-1618-2016 · LAOSiemens Healthcare Diagnostics, Inc.RecallMay 6, 2016FDA classification date
ARK METHOTREXATE ASSAY, ARK METHOTREXATE CALIBRATOR, ARK METHOTREXATE CONTROL, ARK METHOTREXATE CONTROL (CALIBRATION RANK111904 · LAOArk Diagnostics, Inc.510(k)Oct 18, 2011FDA decision date
TDx/TDxFLx Methotrexate II Reagent-List Number 07A12-60 - a reagent system for In Vitro diagnostic use. This reagent system is composed of one bo…Z-1056-2007 · LAOAbbott Diagnostic International, Ltd.RecallJul 20, 2007FDA classification date
TDX(R)/TDX(R)FLX(R)MEHTOTREXATE IIK932615 · LAOAbbott Laboratories510(k)Jul 14, 1993FDA decision date
ACA DU PONT METHOTREXATE (MTHO) METHODK884744 · LAOE.I. Dupont DE Nemours & Co., Inc.510(k)Jan 30, 1989FDA decision date
EMIT & METHOFREXATE ASSAYK833634 · LAOSyva Co.510(k)Dec 22, 1983FDA decision date
TDX METHOTREXATEK830398 · LAOAbbott Laboratories510(k)Mar 10, 1983FDA decision date
EMIT-AND METHOTREXATE ASSAYK811459 · LAOSyva Co.510(k)Jun 9, 1981FDA decision date
EMIT METHATREXATE ASSAYK781381 · LAODade Behring, Inc.510(k)Oct 10, 1978FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗